Cafenol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cafenol

Property Description
Active ingredients Acetaminophen (Paracetamol) and Caffeine
Form Oral solid dosage form (Tablet)
Pharmacological class Combination Analgesic (Non-opioid)
Common use Temporary relief of discomfort and fever
Origin Synthetic chemical compounds

Cafenol is a widely used polycomponent analgesic defined as a fixed-dose combination preparation, containing two distinct active ingredients of synthetic origin. This classification indicates that the medicine is specifically formulated to utilize the combined effects of its components for enhanced therapeutic results. As an Over-the-Counter (OTC) medicine, its primary purpose, clinically recognized across general pharmaceutical practice, is the efficient, temporary, and symptomatic relief of general discomfort and fever.

Classification and Composition

Cafenol is classified as an Analgesic Combination product, primarily comprising the non-opioid pain reliever, Acetaminophen, and Caffeine, a CNS Stimulant from the methylxanthine class. The product's fundamental pharmacological class is derived from the main ingredient, Acetaminophen, a universally recognized antipyretic (fever reducer) and analgesic (pain reliever). The tablet is intended for the oral route of administration and is manufactured as an oral solid dosage form.

The Role of Caffeine and General Purpose

The inclusion of Caffeine in this formulation serves as an adjuvant (helper substance), a role recognized in combination analgesics. The simultaneous administration of these two agents in a fixed dose is intended to offer enhanced efficacy for acute pain relief compared to Acetaminophen administered alone. This means the synergistic action is specifically intended to improve the speed of relief and overall effectiveness for the patient, which is a key differentiating factor from single-ingredient pain relievers. Consequently, the general purpose of Cafenol is to provide enhanced, temporary relief of common symptoms involving discomfort and fever by leveraging this established pharmacological synergy.

Regulatory References

  1. National Library of Medicine, MedlinePlus
  2. Cochrane Review on Caffeine Adjuvant

What side effects are possible with Cafenol?

Possible Side Effects and Safety Information

The regulatory safety profile for this combination analgesic is established by documented classifications of adverse reactions across key physiological systems and explicit warnings regarding systemic risks. This information is classified by government health authorities to ensure a clear understanding of the medicine's risk profile.

Adverse Reactions and Frequency

The most frequently observed adverse reactions are categorized as Common in regulatory documents and often relate to the central nervous system stimulant, caffeine. These effects typically include Insomnia (difficulty sleeping), Nervousness, Restlessness, and a Jittery feeling. Gastrointestinal disturbances, such as Nausea and Abdominal discomfort, are also commonly documented. Other effects, like Palpitations (rapid heart rate) and Tremor, are also listed.

Serious Systemic Risks and Safety Constraints

Official regulatory labeling includes mandatory warnings for rare but serious adverse reactions. The most clinically significant is the risk of Severe Hepatotoxicity (liver damage or failure), which is associated with the acetaminophen component, particularly if the maximum daily dose is exceeded. The label also documents rare occurrences of Severe Cutaneous Adverse Reactions (SCARs), including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).

Specific safety considerations are defined for certain groups. Individuals with pre-existing hepatic impairment or those who consume three or more alcoholic drinks daily are identified as having a heightened risk of severe liver damage. Furthermore, the label explicitly documents the risk of Medication Overuse Headache with long-term, frequent administration and mandates a restriction against combining this product with any other medicine containing acetaminophen.

Overdose and Emergency Response

Overdose and When to Seek Help

A suspected Cafenol overdose, due to its combination of Acetaminophen and Caffeine, is officially classified as a medical emergency requiring urgent intervention as stated in regulatory documents. Early documented signs are often non-specific, including nausea, vomiting, abdominal pain, pallor, and anorexia. These initial symptoms may be mild or even absent, but must not be disregarded as they can precede serious toxicity.

The primary documented risk is the progression to severe hepatic toxicity, which may manifest later as jaundice, pain in the upper right abdomen, and metabolic abnormalities. Severe poisoning can escalate to life-threatening outcomes such as hepatic failure, encephalopathy, cerebral oedema, and death, potentially necessitating liver transplantation.

The caffeine component introduces documented risks of Central Nervous System stimulation, including tremors, restlessness, and convulsions, alongside cardiac disturbances like tachycardia and arrhythmias, which may require specific supportive care.

Regulatory guidance explicitly mandates that individuals must seek immediate medical attention and urgently contact Poison Control or emergency services following any suspected overdose, even if the person feels well. N-acetylcysteine (NAC) is the specific, time-critical antidote for the acetaminophen component, documented to be most effective when administered within the first eight hours of ingestion. Certain patient populations, such as those with non-cirrhotic alcoholic liver disease or those considered glutathione-deplete, are documented in official labeling to have an increased hazard of severe outcomes.

Therapeutic Uses of Cafenol

What Cafenol Treats: Main Uses and Benefits

Cafenol is a combination analgesic used for immediate, symptomatic relief across key domains of discomfort and illness. The medication is utilized in symptomatic pain management, including headaches, and is applied across domains where additional symptomatic support is needed.

The product is commonly used across conditions presenting with systemic or localized discomfort and symptoms related to systemic imbalance. Specific indications include the acute management of tension headaches, mild to moderate migraine headaches, general musculoskeletal aches, and temporary discomforts like menstrual pain and minor dental discomfort. Applied during phases when symptoms become more noticeable, this combination supports patients during difficult episodes by easing distress and contributes to easing the overall symptom load during periods of heightened symptoms.

“It helps address symptom clusters that may become intense or disruptive, providing supportive relief when symptoms interfere with routine activities.”


Symptom Focus: Acute Manifestations The combination is relevant in contexts involving heightened systemic burden and is an applicable option for the acute management of pain that is typically mild to moderate in intensity.

Regulatory References

  1. National Institutes of Health (NIH) StatPearls overview

Eligibility and Restrictions for Use

Population Eligibility for Cafenol

Official regulatory guidelines define specific populations permitted or restricted from using combination analgesics containing Acetaminophen and Caffeine. Use is generally established for adults and adolescents aged 16 years and over.

Absolute Contraindications

Use of this medicine is contraindicated in several specific populations, as listed in official prescribing information:

  • Children under 12 years of age, as safety and efficacy have not been established in this group.
  • Individuals with known hypersensitivity or allergy to Acetaminophen, Caffeine, or any other formulation component.
  • Patients who are currently taking any other product containing Acetaminophen due to the serious risk of overdose and liver damage.

Restricted and Conditional Use

Specific physiological states and underlying health conditions require caution or medical consultation before use:

  • Pregnancy and Lactation: Use is not recommended during pregnancy or while breastfeeding due to the possible stimulating effects of caffeine on the fetus or infant.
  • Organ Function: Patients with pre-existing hepatic (liver) or severe renal (kidney) impairment must seek medical advice prior to use, as the metabolism and excretion of the active ingredients may be compromised.
  • Other Restrictions: Patients should avoid excessive intake of other caffeine sources while taking this medicine.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for this combination medicine (Acetaminophen and Caffeine) details specific substance and drug class interactions that modify its effects or safety profile. This information is based strictly on government-approved drug labels.

Formal Restrictions and Contraindicated Combinations

Co-administration is formally prohibited with Monoamine Oxidase Inhibitors (MAOIs) due to the documented risk of a pharmacodynamic interaction leading to a hypertensive crisis. The medicine is also contraindicated with Fezolinetant, as the Caffeine component can increase Fezolinetant exposure by inhibiting the CYP1A2 enzyme. Chronic ingestion of three or more alcoholic drinks per day is officially noted as a major risk factor, significantly increasing the potential for severe hepatotoxicity from the Acetaminophen component. Individuals with pre-existing hepatic impairment face an elevated interaction risk.

Metabolic and Pharmacokinetic Interactions

The clearance of the Caffeine component is susceptible to CYP1A2 Inhibitors (e.g., Ciprofloxacin), which can lead to increased plasma concentrations. Conversely, Oral Contraceptives are documented to decrease Caffeine clearance. When taken with Anticoagulants like Warfarin, chronic high-dose use of the Acetaminophen component may increase the anticoagulant effect. The substance Cholestyramine reduces Acetaminophen absorption and must be administered at least one hour apart to manage this effect.

Pharmacodynamic Effects

An additive pharmacodynamic effect is documented with other CNS Stimulants, reinforcing the stimulant properties of Caffeine. Excessive intake of high-caffeine foods or beverages should be restricted due to this documented synergistic effect.

Mechanism of Action

Cafenol is a combination formulation that exerts its action through two distinct, complementary mechanisms. The Paracetamol component functions centrally, primarily through the inhibition of cyclooxygenase (COX) enzyme variants, particularly COX-3, within the central nervous system. This molecular interaction suppresses the biosynthesis of certain prostaglandins, which are lipid mediators that typically regulate pain signaling and the hypothalamic temperature control center. *The Caffeine component acts as a non-selective antagonist of adenosine receptors ( A1 and A2 A) throughout neural tissue. By competitively blocking adenosine—a neuromodulator that promotes neuronal inhibition and vasodilation—Caffeine alters the activity of several downstream neurotransmitter systems, promoting increased release of agents like dopamine. This pathway modulation, alongside inhibition of phosphodiesterase**, results in increased intracellular levels of cyclic adenosine monophosphate ( cAMP). The integrated pharmacological effect includes modulation of fatigue perception and augmentation of the central pain response cascade, achieved through Caffeine’s ability to enhance Paracetamol’s absorption and central analgesic mechanism.

Dosage and Administration Information

Official Instructions for Use

The following information describes the standardized administration of Cafenol tablets. These parameters define the method for taking the medicine and are based on established standards for stimulant drug products.

Dosing and Administration Protocol

Age Group Route of Administration Dose Amount Frequency Constraint
Adults and Children 12 Years and Over Oral 100 to 200 milligrams Not more often than every 3 to 4 hours
Children Under 12 Years of Age Oral Do not use Do not use

Special Conditions for Use

  • Procedural Condition: The product is indicated for occasional use only and is not intended to be a substitute for sleep. This defines the clinical context for administration.
  • Dosing Interval: The standardized oral dose is 100 to 200 milligrams, with a requirement that no more than one dose is administered within a minimum time frame of three to four hours.
  • Age Restriction: Standardized protocols prohibit administration to children younger than 12 years of age.

The guidelines establish a standardized sequence for taking the medicine: administering the specified oral dose, observing the minimum age requirement, and adhering to the required waiting period between doses. These steps govern the appropriate use of the nonprescription product.

Recent Clinical Evidence

Research evidence / Overview of Studies for Cafenol (Acetaminophen/Caffeine)

Evidence for Acute Pain Management and Headaches

The primary evidence regarding this combination for acute discomfort research examined systematic reviews and randomized controlled trials (RCTs). These short-term RCTs included Acetaminophen monotherapy as a comparator and studied outcomes related to symptom intensity and the overall analgesic effect in general adult populations. Studies described group patterns of change in reported pain intensity and highlighted differences in analgesic metrics when caffeine was included. Research exploring short-term symptom changes does not determine individual response, and long-term effects are not well characterized. Comparative evidence for the combination's measured effect in certain other types of acute pain data are still emerging.


Evidence for the Antipyretic Function (Fever)

The antipyretic component was studied for outcomes related to changes in elevated body temperature through research examining the single-ingredient Acetaminophen. Findings indicate these studies described patterns related to changes in elevated body temperature over defined time intervals. However, the research provides limited comparative insight into how the caffeine component may vary the antipyretic effect compared to Acetaminophen alone.


Research Limitations and Unstudied Areas

The majority of studies focus on acute, episodic changes, and follow-up durations were often limited. Consequently, there is limited information for long-term outcomes related to continuous use. The primary research was conducted on the general adult population, and data for highly specific patient groups, such as pediatric populations or older adults with pre-existing conditions, remain insufficient. A key research limitation is that studies focused on temporary, mild-to-moderate pain. Comparative evidence is lacking for the combination's effects when addressing pain that is classified as severe, and certainty remains low for prolonged or highly intense symptom activity.

Key Studies & References

  1. Acetaminophen - StatPearls [Internet]
  2. Revised Guidance Document: Acetaminophen Labelling Standard (Health Canada)

Frequently Asked Questions (FAQ)

Common questions about Cafenol (FAQ)

Q: What is Cafenol and what is it used for?

A: Cafenol is a combination medication that contains paracetamol (acetaminophen) and caffeine. It is classified as a non-opioid analgesic (pain reliever) and antipyretic (fever reducer).

It is indicated for the temporary relief of mild to moderate pain, such as headaches, migraines, toothache, and menstrual pain, and to help lower fever associated with colds and flu.

Q: How does Cafenol work to relieve pain?

A: Paracetamol (acetaminophen) is believed to work by elevating the pain threshold and by acting on the heat-regulating center of the brain to reduce fever. Caffeine is added to this combination because it may increase the pain-relieving effects of paracetamol. Caffeine is also a stimulant and may help increase blood vessel tone in the brain, which can be a factor in treating some headaches.

Q: Is Cafenol the same as other combination pain relievers?

A: Cafenol is one type of combination pain reliever. It contains paracetamol and caffeine. Other combination products may contain different active ingredients, such as aspirin, ibuprofen, or different amounts of caffeine. The specific combination of ingredients determines the therapeutic classification and potential interactions of the medication.

Q: What are the potential side effects of taking Cafenol?

A: Like all medications, Cafenol may cause side effects, though they are usually mild. The most common side effects are often related to the caffeine content, and may include restlessness, sleeplessness, or tremor.

Less commonly, the paracetamol component has been associated with mild side effects such as nausea or skin rash. In rare instances, more serious side effects involving the blood or liver have been reported, primarily with prolonged use or overdose.

Q: Can Cafenol be taken by pregnant or breastfeeding women?

A: Pregnant women should consult a healthcare provider before using Cafenol, as high consumption of caffeine is associated with potential risks. For breastfeeding, paracetamol and caffeine are generally considered compatible, but consultation with a doctor or pharmacist is advised to ensure safety and appropriate use for the individual circumstances.

Q: What should I do if I miss a dose of Cafenol?

A: Cafenol is typically taken as needed for pain relief. If you take this medication on a regular schedule and miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, you should skip the missed dose and continue with your regular schedule. Do not take a double dose to make up for a missed one.

How should Cafenol be stored and disposed of?

How to Store and Dispose of Cafenol

Official regulatory labeling dictates specific conditions for storing and disposing of this combination analgesic product to ensure stability and safety.

Storage Requirements

Requirement Instruction
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F).
Environment Store in a dry place and avoid excessive heat or humidity.
Container Keep the product in the original container and close the cap tightly after each use.
Child Safety Must be kept out of the sight and reach of children.

Disposal Instructions

Unused or expired medication should not be disposed of by flushing it down the toilet unless specifically authorized. The best method for disposal is utilizing a drug take-back program or community collection site. Alternatively, official guidelines recommend mixing the product with an undesirable substance, such as dirt or used coffee grounds, sealing the mixture in a bag, and placing it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cafenol found in:

A-Z Index: